[{"address1": "One World Trade Center", "address2": "Suite 8500", "city": "New York", "state": "NY", "zip": "10007", "country": "United States", "phone": "212-220-6633", "website": "https://www.mindmed.co", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Mind Medicine (MindMed) Inc., a clinical stage biopharmaceutical company, develops novel products to treat brain health disorders. The company's lead product candidates include MM-120, which is in phase 2 for the treatment of generalized anxiety disorder and attention deficit hyperactivity disorder; and MM-402, a R-enantiomer of 3,4-methylenedioxymethamphetamine, which is in phase I clinical trials for the treatment of core symptoms of autism spectrum disorder. Mind Medicine (MindMed) Inc. is headquartered in New York, New York.", "fullTimeEmployees": 57, "companyOfficers": [{"maxAge": 1, "name": "Mr. Robert  Barrow", "age": 34, "title": "CEO & Director", "yearBorn": 1989, "fiscalYear": 2023, "totalPay": 931133, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Daniel Rollings Karlin M.A., M.D.", "age": 43, "title": "Chief Medical Officer", "yearBorn": 1980, "fiscalYear": 2023, "totalPay": 658522, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Miriam Halperin Wernli B.A., M.A., M.B.A., MBA, Ph.D.", "age": 70, "title": "Executive President", "yearBorn": 1953, "fiscalYear": 2023, "totalPay": 552464, "exercisedValue": 0, "unexercisedValue": 1030416}, {"maxAge": 1, "name": "Dr. Scott M. Freeman M.D.", "age": 66, "title": "Co-Founder & Clinical Advisor", "yearBorn": 1957, "fiscalYear": 2023, "totalPay": 319730, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Leonard  Latchman", "title": "Co-founder", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Carrie F. Liao CPA, CGMA", "age": 57, "title": "VP & Chief Accounting Officer", "yearBorn": 1966, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Mark R. Sullivan J.D.", "age": 52, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1971, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Francois P. Lilienthal M.B.A., M.D.", "title": "Chief Commercial Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Stephanie  Fagan", "title": "Chief Corporate Affairs Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "auditRisk": 8, "boardRisk": 5, "compensationRisk": 10, "shareHolderRightsRisk": 3, "overallRisk": 8, "governanceEpochDate": 1727740800, "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 2, "previousClose": 5.17, "open": 5.14, "dayLow": 5.05, "dayHigh": 5.44, "regularMarketPreviousClose": 5.17, "regularMarketOpen": 5.14, "regularMarketDayLow": 5.05, "regularMarketDayHigh": 5.44, "beta": 2.357, "forwardPE": -3.977941, "volume": 605090, "regularMarketVolume": 605090, "averageVolume": 860820, "averageVolume10days": 517790, "averageDailyVolume10Day": 517790, "bid": 5.39, "ask": 5.44, "bidSize": 200, "askSize": 100, "marketCap": 440538976, "fiftyTwoWeekLow": 2.41, "fiftyTwoWeekHigh": 12.22, "fiftyDayAverage": 6.1668, "twoHundredDayAverage": 7.018425, "currency": "USD", "enterpriseValue": 171423280, "floatShares": 59750464, "sharesOutstanding": 81430496, "sharesShort": 10362529, "sharesShortPriorMonth": 9905914, "sharesShortPreviousMonthDate": 1724976000, "dateShortInterest": 1727654400, "sharesPercentSharesOut": 0.1273, "heldPercentInsiders": 0.01039, "heldPercentInstitutions": 0.52203, "shortRatio": 13.34, "shortPercentOfFloat": 0.1274, "bookValue": 2.803, "priceToBook": 1.9300749, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -102041000, "trailingEps": -2.04, "forwardEps": -1.36, "exchange": "NMS", "quoteType": "EQUITY", "symbol": "MNMD", "underlyingSymbol": "MNMD", "shortName": "Mind Medicine (MindMed) Inc.", "longName": "Mind Medicine (MindMed) Inc.", "firstTradeDateEpochUtc": 1479220200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "82effaa6-cea3-362e-b9a1-33a692529ba0", "gmtOffSetMilliseconds": -14400000, "currentPrice": 5.41, "targetHighPrice": 55.0, "targetLowPrice": 14.0, "targetMeanPrice": 26.25, "targetMedianPrice": 20.0, "recommendationMean": 1.7, "recommendationKey": "buy", "numberOfAnalystOpinions": 8, "totalCash": 243132000, "totalCashPerShare": 3.37, "totalDebt": 24251000, "quickRatio": 5.81, "currentRatio": 5.919, "debtToEquity": 12.003, "returnOnAssets": -0.27571, "returnOnEquity": -0.66256, "freeCashflow": -32174750, "operatingCashflow": -73776000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-10-14"}]